Market Currents
Mylan's (MYL +0.5%) subsidiary, Mylan Pharmaceuticals, has received final FDA approval for its...
-
Friday, August 10, 2012, 12:30 PM ETMylan's (MYL +0.5%) subsidiary, Mylan Pharmaceuticals, has received final FDA approval for its Modafinil Tablets, the generic version of Teva's (TEVA +0.2%) Provigil Tablets. The drug is designed to improve wakefulness in adult patients with narcolepsy, obstructive sleep apnea and shift work disorder.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
